Dinesh Raghavan, Srinivasan Veeraraghavan, T E Sheeja, Anandaraj Muthuswamy, Srambikkal Hamza
a ICAR-Indian Institute of Spices Research , Kozhikode, Kerala , India.
Crit Rev Microbiol. 2017 Sep;43(5):546-566. doi: 10.1080/1040841X.2016.1270895. Epub 2017 Mar 30.
Endophytic actinobacteria, which reside in the inner tissues of host plants, are gaining serious attention due to their capacity to produce a plethora of secondary metabolites (e.g. antibiotics) possessing a wide variety of biological activity with diverse functions. This review encompasses the recent reports on endophytic actinobacterial species diversity, in planta habitats and mechanisms underlying their mode of entry into plants. Besides, their metabolic potential, novel bioactive compounds they produce and mechanisms to unravel their hidden metabolic repertoire by activation of cryptic or silent biosynthetic gene clusters (BGCs) for eliciting novel secondary metabolite production are discussed. The study also reviews the classical conservative techniques (chemical/biological/physical elicitation, co-culturing) as well as modern microbiology tools (e.g. next generation sequencing) that are being gainfully employed to uncover the vast hidden scaffolds for novel secondary metabolites produced by these endophytes, which would subsequently herald a revolution in drug engineering. The potential role of these endophytes in the agro-environment as promising biological candidates for inhibition of phytopathogens and the way forward to thoroughly exploit this unique microbial community by inducing expression of cryptic BGCs for encoding unseen products with novel therapeutic properties are also discussed.
内生放线菌存在于宿主植物的内部组织中,由于它们能够产生大量具有多种生物活性和不同功能的次生代谢产物(如抗生素),因此受到了广泛关注。本综述涵盖了关于内生放线菌物种多样性、植物内栖息地及其进入植物的机制的最新报道。此外,还讨论了它们的代谢潜力、所产生的新型生物活性化合物,以及通过激活隐秘或沉默的生物合成基因簇(BGCs)来揭示其隐藏的代谢库以引发新型次生代谢产物产生的机制。该研究还回顾了经典的保守技术(化学/生物/物理诱导、共培养)以及现代微生物学工具(如下一代测序),这些技术正被有效地用于揭示这些内生菌产生的新型次生代谢产物的大量隐藏支架,这随后将引发药物工程领域的一场革命。还讨论了这些内生菌在农业环境中作为抑制植物病原体的有前景的生物候选者的潜在作用,以及通过诱导隐秘BGCs的表达来充分利用这个独特的微生物群落以编码具有新型治疗特性的未知产物的未来发展方向。